Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
This grant funds the establishment and support of biospecimen banks for clinical trials.
About this program
The Limited Competition grant aims to support the National Cancer Institute's (NCI) National Clinical Trials Network Biospecimen Banks and the Early-Phase and Experimental Clinical Trials Biospecimen Bank. These biobanks are essential for collecting, storing, and distributing biospecimens that are critical for cancer research and clinical trials. The funding will facilitate the infrastructure necessary for these biobanks to operate effectively, ensuring that researchers have access to high-quality biospecimens for their studies. This grant is intended for institutions and organizations involved in cancer research, particularly those that are part of the NCI's clinical trials network. By providing financial support, the grant aims to enhance the capabilities of these biobanks, allowing them to better serve the research community and contribute to advancements in cancer treatment and understanding. The focus is on ensuring that the biospecimens collected are representative and of high quality, which is crucial for the success of clinical trials.
Eligibility
Eligible entities include institutions and organizations involved in cancer research, particularly those associated with the NCI's clinical trials network.